This multicenter, open-label, prospective analysis evaluated the long-term safety and efficacy of the Kamra small-aperture intracorneal inlay. Source: AAO
Oyster Point Pharma reported positive preliminary results from a phase 2b trial testing their novel drug for dry eye disease. Source: AAO
This retrospective review assessed the risk of severe vision loss after orbital surgery. Source: AAO
This open-label multicenter study evaluated the human monoclonal antibody, cemiplimab, for treatment of advanced cutaneous squamous-cell carcinoma. Cemiplimab is a high-affinity monoclonal antibody directed against programmed death 1 (PD-1). Source: AAO
This week, a drop-sized lawsuit is squeezed out of deliberations by the U.S. Supreme Court, an orange a day may keep macular degeneration away and Japan’s Takeda is one step closer to buying Shire for $62 billion. Source: AAO
This retrospective study evaluated the sensitivity and specificity of brain MRI to predict endocrinopathy in children with optic nerve hypoplasia (ONH). Source: AAO
Alleye, a mobile medical application developed to monitor progression of patients with AMD, was approved by the FDA earlier this week. Source: AAO
Due to lack of sterility assurance, the FDA is urging healthcare professionals not to use sterile drug products produced and distributed by Ranier’s Compounding Laboratory, Ranier’s Pharmacy and Ranier’s RX Laboratory, Jeannette, Pennsylvania. Source: AAO
Investigators report data from 2 randomized phase 3 trials assessing the safety and efficacy of lampalizumab, a complement factor D inhibitor, for the treatment of geographic atrophy. Source: AAO
This study describes the 3-year changes in anterior and posterior corneal irregular astigmatism and curvature after small incision lenticule extraction. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
